The FDA has expanded the approved use of regorafinib (Stivarga, Bayer HealthCare Pharmaceuticals) to include the treatment of patients with hepatocellular carcinoma (HCC) who have been treated with sorafenib. This is the first FDA-approved treatment for liver cancer in almost a decade.

The FDA has cleared midostaurin (Rydapt, Novartis) for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) who have the FLT3 gene mutation, in combination with chemotherapy.

The current state of Alzheimer’s disease (AD) research is nothing to crow about, according to BioSpace reporter Mark Terry. One of the problems with developing drugs for the disease is that it isn’t very well understood, he says.

Speaking to an audience at Health Datapalooza hosted by AcademyHealth, Department of Health and Human Services Secretary Dr. Tom Price said his administration is “fully committed” to data and health information technology (IT) but said government oversight has created too many obstacles, according to a report from FierceHealthcare.

After striking a deal with the conservative Freedom Caucus, House GOP leaders appeared hopeful that a vote on their dormant health care bill would occur this week––but no such luck. Now moderates are refusing to approve the plan because it allows states to cut insurance coverage for people with pre-existing conditions.

A recent study in Health Affairs projects physician payment rates under MACRA, comparing them to what they would have looked like had MACRA not been passed.

One of the ideas that surfaces in discussions to replace the ACA is to allow health insurers to not cover some of the services that the law currently makes them cover. Opponents of Obamacare call them skinny plans.

The Joint Commission conducts surprise inspections of hospitals at least once every 39 months. Just what the commission finds, however, is rarely disclosed to the public, according to ProPublica, a not-for-profit news gathering organization.

A program that penalizes hospitals for high early readmission rates of heart attack patients may be unfairly penalizing hospitals that serve a large proportion of African-Americans and those with more-severe illness, a study from the University of Texas Southwestern Medical Center suggests.

Truven Health Analytics has released its annual study identifying the 15 top U.S. health systems, based on balanced, system-wide clinical and administrative performance.

Cancer patients and their families have bought into treatments that don’t work, cost a fortune, or cause life-threatening adverse effects, according to a report from Kaiser Health News (KHN).

The White House has announced that President Trump’s administration would maintain critical funding for health plans under the Patient Protection and Affordable Care Act (PPACA) in a move to reduce the chances of a government shutdown, according to the Wall Street Journal.

The far-right House Freedom Caucus, which has been blocking President Trump’s plan to dismantle the Patient Protection and Affordable Care Act (PPACA), has approved a new, more-conservative version of the GOP health care bill, according to The New York Times.

The caucus released the following statement:

Yesterday, it looked as if Anthem and Express Scripts would go their separate ways for sure. Today, there’s a sliver of hope that the 10-year-contract between the nation’s biggest PBM and one of the biggest health insurance companies might yet be salvaged.

It didn’t take long for the fallout to begin after House Speaker Paul Ryan yesterday said that the spending bill lawmakers are hammering out won’t include subsidies for health plans that participate in the ACA marketplace.